# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA636951 | F | Compound was evaluated for minimum effective dose Actinobacillus pleuropneumonia, peroral dose administration | Actinobacillus pleuropneumoniae | 1 | organism-based format | Scientific Literature | ||
2. | ALA636952 | F | Compound was evaluated for minimum effective dose against Actinobacillus pleuropneumonia, peroral dose administration | Actinobacillus pleuropneumoniae | 1 | organism-based format | Scientific Literature | ||
3. | ALA636953 | F | Compound was evaluated for minimum effective dose against Actinobacillus pleuropneumonia peroral dose administration | Actinobacillus pleuropneumoniae | 1 | organism-based format | Scientific Literature | ||
4. | ALA636954 | F | In vitro antibacterial activity against anaerobically grown Actinobacillus pleuropneumoniae (54B004) | Actinobacillus pleuropneumoniae | 53 | organism-based format | Scientific Literature | ||
5. | ALA1259519 | F | Antimicrobial activity against Actinobacillus pleuropneumoniae NB001 after 17 hrs by serial agar dilution method | Actinobacillus pleuropneumoniae | 10 | organism-based format | Scientific Literature | ||
6. | ALA4668761 | F | Antibacterial activity against Actinobacillus pleuropneumoniae after 48 hrs by CLSI protocol based broth microdilution assay | Actinobacillus pleuropneumoniae | 6 | organism-based format | Scientific Literature |